№ files_lp_4_process_3_079533
File format: docx
Character count: 66188
File size: 116 KB
Year:
2015
Location:
Geneva, Switzerland
Topic:
Access to medicines, right to health
Document type:
Report
Organization:
United Nations Human Rights Council
Author:
Chairperson-Rapporteur Faisal bin Abdulla al-Henzab
Audience:
UN member states, human rights stakeholders
Period covered:
18–20 February 2015
Date of adoption:
13 April 2015
Related resolutions:
HRC Resolution 26/28, HRC Resolution 6/13
Annexes:
Provisional agenda, List of participants
Summary:
Intergovernmental report detailing the discussions, conclusions, and recommendations of the 2015 Social Forum on access to medicines, highlighting legal frameworks, best practices, and stakeholder perspectives.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Dates:
October 18–20, 2021
Time Zones:
Pacific Time and Eastern Time
Organization:
APRIL
Type of Document:
Conference Agenda
Format:
Virtual Conference
Subject:
Disability Advocacy and Independent Living
Topics:
COVID-19 implications, Diversity and Inclusion, Housing Partnerships, Membership Meeting, Disability Data, Transportation in Rural Areas, Peer Support, FEMA Emergency Relocation, Higher Education Accommodations
Key Participants:
Steven Morales (Cherokee Nation), Acting Administrator Barkoff
Audience:
Disability advocates, CIL staff, SILCs, researchers, policy makers, APRIL members
Year:
2018
Location:
Can Tho, Viet Nam
Event Type:
International Conference
Theme:
Climate Action, Sustainable Development Goals
Organizer:
ASEM (Asia-Europe Meeting)
Participants:
Government officials, diplomats, international organizations, development agencies
Countries Represented:
Australia, Belgium, Cambodia, China, Czech Republic, Denmark, EU, Finland, France, Germany, Hungary, Indonesia, Italy, Japan, Kazakhstan, Lao PDR, Luxembourg, Mongolia, Myanmar, Netherlands, New Zealand, Pakistan, Philippines, Poland, Romania, Russia, Switzerland, Thailand, United Kingdom, Viet Nam
Duration:
18–20 June 2018
Document Type:
List of Participants
Sponsoring Ministries/Agencies:
Ministry of Foreign Affairs of Viet Nam, ASEAN Secretariat, various embassies and international organizations
Year:
2026
Jurisdiction:
West Virginia, United States
Document Type:
Legislative Bill
Legislative Body:
West Virginia Legislature
Introduced By:
Delegates Coop-Gonzalez, Foggin, and Horst
Date Introduced:
February 9, 2026
Committee Referred:
Judiciary Committee
Subject:
Firearms regulation, concealed weapons, age restrictions
Target Audience:
Lawmakers, legal professionals, public safety authorities
Legal References:
§61-7-3, §61-7-6, §61-7-7 of the West Virginia Code
Status:
Introduced, pending committee review
Document Scope:
Amends provisions on carrying concealed deadly weapons for persons 18 to 20 years old
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Document type:
Q&A guidance
Jurisdiction:
Japan
Subject:
Import and shipment of medicines and medical devices
Issuing authority:
Ministry of Health, Labour and Welfare
Intended users:
Individuals importing or sending medicines for personal use
Scope:
Prescription medicines, injections, syringes, and medical devices
Import purpose:
Personal use
Regulatory framework:
Pharmaceutical and Medical Device regulations
Application system:
Online Import Confirmation system
Related forms:
Import Confirmation Application Form (Form 12); Explanation of Pharmaceutical Product (Form 13)
Year:
2024
Region / city:
Denmark
Topic:
Medicine, Health Economics
Document type:
Template
Organization / institution:
Danish Medicines Council
Author:
Danish Medicines Council
Target audience:
Pharmaceutical companies
Period of validity:
Ongoing
Approval date:
10 September 2024
Date of changes:
1 April 2025
Version:
2.5
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Year:
2020
Region / city:
UK
Theme:
Medicines Information
Document type:
List
Organization / institution:
NHS
Author:
UKMi
Target audience:
NHS Medicines Information Services
Period of validity:
Ongoing, updated quarterly
Approval date:
November 2020
Date of changes:
May 2020
Note:
Year
Subject:
Medicine Formularies, Health Policy
Document Type:
Form, Application
Institution:
Ministry of Health
Author:
Applicant (Consultant, Specialist, Medical Officer, Pharmacist)
Target Audience:
Healthcare Professionals, Drug and Therapeutic Committee
Context:
Form used to propose the inclusion of a medicine or indication from the Ministry of Health Medicines Formulary into an institution’s Medicines Formulary for approval by the institution’s Drug and Therapeutic Committee.
Year:
Not specified
Region / City:
Malaysia
Topic:
Pharmaceutical registration and formulary listing
Document Type:
Application Form
Organization / Institution:
Ministry of Health Malaysia
Author:
Not specified
Target Audience:
Pharmaceutical companies, regulatory authorities
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Health, Pharmaceuticals
Document Type:
Informational Resource
Organization / Institution:
U.S. Food and Drug Administration
Target Audience:
Consumers, Healthcare Providers, Information Professionals, Researchers
Year:
2018
Region / City:
Wellington, New Zealand
Topic:
Medicine administration
Document type:
Guideline
Organization / Institution:
New Zealand Nurses Organisation
Author:
New Zealand Nurses Organisation
Target audience:
Nurses, midwives
Period of validity:
Not specified
Approval date:
2018
Date of changes:
Not specified
ISBN:
978-1-877461-66-8
Year:
2023
Region / City:
Geneva
Topic:
Greenhouse Gas Monitoring
Document Type:
Draft Resolution
Institution:
World Meteorological Organization (WMO)
Author:
President of INFCOM through the Executive Council
Target Audience:
Parties to the Paris Agreement, international stakeholders in climate change research and monitoring
Period of Effectiveness:
2023–2027
Approval Date:
11.IV.2023
Date of Amendments:
N/A
Description:
Draft resolution for establishing a WMO-coordinated global greenhouse gas monitoring infrastructure to support the Paris Agreement’s implementation.
Year:
2024
Region / City:
Geneva
Topic:
Climate Data Management
Document Type:
Resolution Draft
Organization:
World Meteorological Organization
Author:
Chair of the Standing Committee on Information Management and Technology (SC-IMT)
Target Audience:
WMO Members
Period of Action:
2024-2027
Approval Date:
15 April 2024
Date of Changes:
Not specified